Professor Nestor is a clinician-scientist and joined the Queensland Brain Institute in October 2017. He also has a conjoint appointment at Mater Misericordiae Ltd (Mater Hospital).
He aims to relate the neuropsychological and behavioural profiles of degenerative dementias, such as Alzheimer's disease and frontotemporal dementia, to regional brain damage through neuroimaging (MRI and PET) and histopathological analysis. His particular interest is the pathological landscape of incipient dementia (so-called mild cognitive impairment).
By studying patients in this category he hopes to develop a greater understanding of the regions of highest vulnerability to neurodegeneration in different pathologies. Identification of such regions may potentially lead to a better understanding of what makes these regions vulnerable in the first place. His research ultimately aims to improve diagnostic certainty and prognostic markers of decline - both of which are relevant to therapeutic development.
To this end, a major focus of his is on developing novel approaches to MR imaging for single subject pathological diagnoses that can be exported into the everyday clinical setting; this has included to date diffusion imaging (Sajjadi et al, 2013) and quantitative susceptibility mapping (Acosta-Cabornero et al, 2013).
Patient Referrals
Professor Nestor’s memory clinic is located at Mater Public Hospital, South Brisbane. Specialists wishing to refer patients to this service should send the referral to Mater Memory Clinic.
Group leader
Professor Peter Nestor
Professor in Neuroscience, Queensland Brain Institute
News
- University of Queensland researchers have received two $3 million grants from the National Health and Medical Research Council (NHMRC) to accelerate knowledge and treatment of Alzheimer’s disease, and to improve gynaecological cancer treatment.
- Researchers from the Queensland Brain Institute have secured more than $3.2million in National Health and Medical Research Council Ideas Grants.
- A pioneering treatment for Alzheimer’s disease is being tested in a small safety trial underway in Brisbane.
Research Areas
- Dementia
- Neurodegeneration
- Neuropsychology
- Neuroimaging
- Alzheimer's disease
- Frontotemporal Lobar Degeneration